Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine

This study assessed response rates to combination dacarbazine (DTIC), BCNU (carmustine), cisplatin and tamoxifen (DBPT) chemotherapy in patients with progressive metastatic melanoma previously treated with DTIC, as an evaluation of DBPT as a second-line regimen, and as an indirect comparison of DBPT...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Propper, D J, Braybrooke, J P, Levitt, N C, O'Byrne, K, Christodoulos, K, Han, C, Talbot, D C, Ganesan, T S, Harris, A L
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2000
Teme:
Regular Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363219/
https://ncbi.nlm.nih.gov/pubmed/10839287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1141
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki